ArticleCancer science2023

Pemetrexed combined with dual immune checkpoint blockade enhances cytotoxic T lymphocytes against lung cancer.

Mei-Chih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.